Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV
Wen Jiang(Qingdao University), Xun Gui(Bioscience (China)), Dadi Zeng, Ben Chen, Rongjuan Wang, Shuang Wang, Min Zhang(Henan University of Science and Technology), An Wang, Gang Li(Beijing Center for Disease Prevention and Control), Youhua Xie(Shanghai Medical College of Fudan University), Mingzhu Wang(Zhejiang Chinese Medical University), Chenjian Gu(Washington University in St. Louis), Huilin Chen(South China Agricultural University), Junchao Wang(Wuhan University), Jinchao Zhang, Shasha Jiao, Wei Xu(Beijing Geriatric Hospital)
Cited by 27
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids
|Protein & Cell|2020|397
The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
|Signal Transduction and Targeted Therapy|2020|363
Rapid and ultrasensitive electromechanical detection of ions, biomolecules and SARS-CoV-2 RNA in unamplified samples
|Nature Biomedical Engineering|2022|332